Bristol-Myers Squibb Co

Common Name
Bristol-Myers Squibb
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
34,100
Ticker
BMY
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Bristol-Myers Squibb Company is a renowned pharmaceutical corporation engaged in the discovery, development, and distribution of innovative medicines. The company's core focus lies in providing therap...

Bristol-Myers Squibb's Climate Target Data Preview

As of 2023, Bristol-Myers Squibb has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Bristol-Myers Squibb ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total, Scope 3 - Fuel- and Energy-Related Services (Cat. 3)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2033

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Bristol-Myers Squibb's Greenhouse Gas Emissions Pathways

As of 2023, Bristol-Myers Squibb has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories.

Want Full Access to Bristol-Myers Squibb's Climate Targets Dataset?
Sign Up